MedicaMetrix® is a Delaware company that produces urological medical devices with demonstrated “comparative effectiveness”, i.e., that reduce the cost of healthcare, while improving clinical outcomes.
MedicaMetrix’s first product, ProstaMetric®, enables the quantitative measurement of prostate volume early in the diagnostic process that will become the new standard for prostate volume and prostate disease evaluation. ProstaMetric1 is a medical device for more effective prostate cancer diagnosis and monitoring with regulatory approval (CE Mark), entering a billion dollar market with no direct competitor. I ts volume can also be used in the evaluation and management of benign prostatic hyperplasia (BPH).
1 ProstaMetric was originally branded as “ProstaGlove”
Site last updated: 02/2018
All contents © Copyright MedicaMetrix, Inc. 2007-2015. All Rights Reserved. All content of this Internet site is owned or controlled by MedicaMetrix, Inc. and is protected by worldwide copyright laws. You may download content only for your personal use for non-commercial purposes, but no modification or further reproduction of the content is permitted. The content may otherwise not be copied or used in any way.
ProstaMetric® and MedicaMetrix® are registered trademarks of MedicaMetrix, Inc. registered in the United States and internationally. The trademarks, service marks, trade names, trade dress and products in this Internet site are protected in the United States and internationally. No use of any of these may be made without the prior, written authorization of MedicaMetrix, Inc., except to identify the products or services of the company